- Name: He Xia
- Title: Associate Chief Technician, Head of Clinical Laboratory Testing Group
- Email:
- Phone:
Profile
Associate Senior Technologist and Head of the Clinical Laboratory Testing Group. Serving as an ISO15189-authorized signatory for Hematology and Body Fluid, I hold committee positions in the China Anti-Cancer Association and the Precision Medicine Association. My expertise lies in building diagnostic models using routine lab indicators to support clinical decision-making.
Interests
- Clinical hematology and body fluid analysis;
- Quality management and standardization of pre-analytical/analytical processes in clinical laboratory settings.
Education
Master of Clinical Laboratory Diagnostics, Sun Yat-sen University, Guangzhou, China
Publications
1. Ya-Xian Wu; Bo-Yu Tian; Xin-Yuan Ou; Meng Wu; Qi Huang; Run-Kun Han; Xia He*; Shu-Lin Chen*; A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients, CANCER IMMUNOL IMMUN, 2024, 73(1): 14 .
2. He X#, Xue N#, Liu X#, Tang X, Peng S, Qu Y, Jiang L, Xu Q*, Liu W*, Chen S*. A novel clinical model for predicting malignancy of solitary pulmonary nodules: a multicenter study in chinese population. Cancer Cell Int. 2021 Feb 17;21(1):115.
3. Chen S#, Huang H#., Liu Y#, Lai C, Peng S, Zhou L, Chen H*, Xu Y*, He X*. A multi-parametric prognostic model based on clinical features and serological markers predicts overall survival in non-small cell lung cancer patients with chronic hepatitis B viral infection. Cancer Cell Int 20, 555 (2020).